Sign In $

Vince Carter

Atlanta Hawks
Pos: SHW
Status: Inactive
player props
FPTS 4 7 10 13 16 19 22 25 28 31 SAL $3K $3.1K $3.1K $3.2K $3.2K $3.2K $3.3K $3.3K $3.4K $3.4K
  • FPTS: 4.5
  • FPTS: 30.75
  • FPTS: 3.25
  • FPTS: 10.5
  • FPTS: 6
  • FPTS: 2.5
  • FPTS: 1.25
  • FPTS: 3.25
  • FPTS: 1.5
  • FPTS: 10
  • FPTS: 12
  • FPTS: 12.25
  • FPTS: 9.75
  • FPTS: 9.5
  • FPTS: 12
  • FPTS: 6.75
  • SAL: $3.4K
  • SAL: $3.1K
  • SAL: $3.3K
  • SAL: $3.3K
  • SAL: $3.2K
  • SAL: $3.1K
  • SAL: $3K
  • SAL: $3K
  • SAL: $3K
  • SAL: $3K
  • SAL: $3K
  • SAL: $3K
  • SAL: $3K
  • SAL: $3K
  • SAL: $3K
  • SAL: $3K
02/08 02/09 02/11 02/13 02/21 02/23 02/25 02/27 02/29 03/01 03/03 03/07 03/08 03/09 03/11
Date Opp DKSAL FDSAL DKFPTS FDFPTS min fg% fgm fga ftm dd fta tfoul 3pm usg 3pa 3p% 2pm 2pa pfoul reb ffoul ast fouls stl pace blk ft% to 2p% pts td oreb
2020-03-11 vs. NYK $3K $3.5K 6.75 6.2 12.65 0.4 2 5 0 0 0 0 1 15.81 2 0.5 1 3 4 1 0 0 4 0 5 0 0 0 0.33 5 0 0
2020-03-09 vs. CHA $3K $3.5K 12 10.5 15.13 0.5 3 6 0 0 0 0 3 16.73 5 0.6 0 1 1 0 0 1 1 0 6 0 0 0 0 9 0 0
2020-03-07 @ MEM $3K $3.5K 9.5 8.9 18.9 0.29 2 7 0 0 0 0 1 15.51 6 0.17 1 1 1 2 0 1 1 0 7 0 0 0 1 5 0 0
2020-03-06 @ WAS $3K $3.5K 9.75 8.2 16.75 0.75 3 4 0 0 0 0 2 11.94 3 0.67 1 1 0 1 0 0 0 0 5 0 0 1 1 8 0 0
2020-03-02 vs. MEM $3K $3.5K 12.25 11.1 15.2 0.22 2 9 0 0 0 0 2 24.55 7 0.29 0 2 1 3 0 1 1 0 7 0 0 0 0 6 0 2
2020-02-29 vs. POR $3K $3.5K 12 12.8 12.18 0.2 1 5 0 0 0 0 1 19.7 4 0.25 0 1 0 4 0 0 0 2 5 0 0 1 0 3 0 1
2020-02-28 vs. BKN $3K $3.5K 10 11.9 11.58 0.2 1 5 0 0 0 0 0 18.41 1 0 1 4 0 2 0 1 0 2 4 0 0 0 0.25 2 0 1
2020-02-26 vs. ORL $3K $3.5K 1.5 1 3.95 1 1 1 0 0 0 0 0 20.25 0 0 1 1 1 0 0 0 1 0 2 0 0 1 1 2 0 0
2020-02-24 @ PHI $3K $3.5K 3.25 4.2 5.8 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 1 0 0 1 0 0 0 0 0 0
2020-02-22 vs. DAL $3K $3.5K 1.25 1.2 10.57 0 0 1 0 0 0 0 0 3.78 0 0 0 1 2 1 0 0 2 0 1 0 0 0 0 0 0 0
2020-02-20 vs. MIA $3.1K $3.5K 2.5 2.4 4.28 0 0 1 0 0 0 0 0 9.35 0 0 0 1 1 2 0 0 1 0 1 0 0 0 0 0 0 0
2020-02-12 @ CLE $3.2K $3.5K 6 5.4 8.37 0.33 1 3 0 0 0 0 1 14.34 2 0.5 0 1 1 2 0 0 1 0 2 0 0 0 0 3 0 1
2020-02-10 @ ORL $3.3K $3.7K 10.5 9 14.65 0.75 3 4 0 0 0 0 3 10.92 3 1 0 1 2 0 0 0 2 0 4 0 0 0 0 9 0 0
2020-02-09 vs. NYK $3.3K $3.7K 3.25 3.2 2.53 0.5 1 2 0 0 0 0 0 31.62 1 0 1 1 1 1 0 0 1 0 2 0 0 0 1 2 0 0
2020-02-07 @ BOS $3.1K $3.5K 30.75 29.8 24.3 0.43 3 7 2 0 2 0 2 20.08 6 0.33 1 1 2 9 0 4 2 1 9 1 1 3 1 10 0 2
2020-02-05 @ MIN $3.4K $3.8K 4.5 4 16.32 0.5 1 2 0 0 0 0 1 9.8 2 0.5 0 0 1 0 0 0 1 1 4 0 0 2 0 3 0 0
2020-02-03 vs. BOS $3.5K $3.9K 12.5 15.4 18.5 0.29 2 7 0 0 0 0 0 15.14 4 0 2 3 1 2 0 0 1 0 6 3 0 0 0.67 4 0 1
2020-02-01 @ DAL $3.4K $3.9K 18.25 19 24.35 0.33 4 12 2 0 2 0 0 21.16 4 0 4 8 4 5 0 0 4 0 12 1 1 0 0.5 10 0 1
2020-01-30 vs. PHI $3.3K $3.7K 28 29.2 23.82 0.5 4 8 4 0 4 0 2 18.07 6 0.33 2 2 4 6 0 0 4 1 11 2 1 1 1 14 0 0
2020-01-28 @ TOR $3.2K $3.5K 23.75 24 17.93 0.44 4 9 0 0 0 0 2 23.78 6 0.33 2 3 2 5 0 2 2 2 10 0 0 1 0.67 10 0 0
2020-01-26 vs. WAS $3K $3.5K 16.25 17.6 15.6 0.5 2 4 0 0 0 0 1 11.95 3 0.33 1 1 3 3 0 2 3 1 4 1 0 0 1 5 0 0
2020-01-24 @ OKC $3K $3.5K 4.5 4.4 10.45 0.25 1 4 0 0 0 0 0 15.31 3 0 1 1 1 2 0 0 1 0 3 0 0 0 1 2 0 1
2020-01-22 vs. LAC $3.1K $3.5K 9.25 7.6 12.5 0.17 1 6 0 0 0 0 1 27.71 5 0.2 0 1 0 3 0 2 0 0 7 0 0 2 0 3 0 1
2020-01-20 vs. TOR $3.1K $3.5K 12.5 11.9 8.62 0.67 2 3 0 0 0 0 2 20.09 3 0.67 0 0 1 2 0 1 1 0 4 1 0 1 0 6 0 0
2020-01-18 vs. DET $3K $3.5K 8.75 9.2 10.13 0.29 2 7 0 0 0 0 1 27.64 5 0.2 1 2 0 1 0 0 0 0 7 1 0 0 0.5 5 0 0
2020-01-17 @ SAS $3K $3.5K 22.25 21.1 22.48 0.57 4 7 3 0 4 0 3 17.95 4 0.75 1 3 0 3 0 1 0 1 9 0 0.75 1 0.33 14 0 1
2020-01-14 vs. PHX $3K $3.5K 3.25 4.2 8.9 0 0 2 0 0 0 0 0 8.99 1 0 0 1 0 1 0 0 0 0 2 1 0 0 0 0 0 0
2020-01-12 @ BKN $3K $3.5K 17.5 19.4 14.45 0.5 3 6 0 0 0 0 2 16.61 5 0.4 1 1 1 2 0 0 1 3 6 0 0 0 1 8 0 0
2020-01-10 @ WAS $3K $3.5K 3.5 5 8.67 0 0 2 0 0 0 0 0 13.84 2 0 0 0 1 0 0 0 1 1 3 1 0 1 0 0 0 0
2020-01-08 vs. HOU $3.1K $3.5K 0 0 10 0 0 1 0 0 0 0 0 4 0 0 0 1 2 0 0 0 2 0 1 0 0 0 0 0 0 0
2020-01-06 vs. DEN $3.2K $3.5K 9.5 11.4 18.45 0 0 4 0 0 0 0 0 10.1 4 0 0 0 1 2 0 2 1 0 4 2 0 0 0 0 0 0
2020-01-04 vs. IND $3.3K $3.5K 8.25 7.1 18.05 0.14 1 7 0 0 0 0 1 18.46 4 0.25 0 3 5 3 0 1 5 0 8 0 0 1 0 3 0 0
2020-01-03 @ BOS $3.1K $3.5K 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
2019-12-30 @ ORL $3K $3.5K 10.25 9.6 20.8 0.5 1 2 2 0 2 0 0 8.73 1 0 1 1 1 3 0 2 1 0 3 0 1 1 1 4 0 1
2019-12-28 @ CHI $3K $3.5K 9.5 9.3 12.03 0 0 4 2 0 2 0 0 23.97 3 0 0 1 0 4 0 1 0 0 7 1 1 2 0 2 0 0
2019-12-27 vs. MIL $3.2K $3.5K 3 3 12.45 0 0 1 0 0 0 0 0 5.33 1 0 0 0 1 0 0 2 1 0 1 0 0 0 0 0 0 0
2019-12-23 @ CLE $3.3K $3.7K 13.25 13.5 15 0.2 1 5 0 0 0 0 1 14.21 3 0.33 0 2 2 5 0 1 2 0 4 1 0 0 0 3 0 1
2019-12-21 @ BKN $3.5K $3.7K 1.25 1.2 8.03 0 0 3 0 0 0 0 0 14.94 2 0 0 1 1 1 0 0 1 0 3 0 0 0 0 0 0 0
2019-12-19 vs. UTA $3.4K $3.7K 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
2019-12-17 @ NYK $3K $3.6K 22.5 22.5 23.83 0.56 5 9 1 0 3 0 4 17.88 7 0.57 1 2 2 0 0 1 2 0 10.5 2 0.33 0 0.5 15 0 0
2019-12-15 vs. LAL $3K $3.7K 13.75 14.2 21 0.3 3 10 0 0 0 0 1 20.3 4 0.25 2 6 4 1 0 2 4 1 10 0 0 0 0.33 7 0 0
2019-12-13 vs. IND $3K $3.7K 4.25 4.2 12.58 0 0 2 0 0 0 0 0 8.46 1 0 0 1 1 1 0 2 1 0 2 0 0 0 0 0 0 0
2019-12-11 @ CHI $3.2K $3.6K 9.75 9.6 12.83 0.2 1 5 1 0 2 0 1 21.45 2 0.5 0 3 0 3 0 0 0 1 7 0 0.5 1 0 4 0 0
2019-12-10 @ MIA $3.3K $3.6K 22.75 19.6 26.13 0.4 4 10 0 0 0 0 4 20.39 10 0.4 0 0 2 3 0 4 2 0 12 0 0 2 0 12 0 0
2019-12-08 @ CHA $1.5K $6K 24.25 23.2 20.42 0.64 7 11 0 0 0 0 3 24.8 6 0.5 4 5 2 1 0 2 2 0 11 1 0 1 0.8 17 0 1
2019-12-04 vs. BKN $3.1K $3.5K 4 5 11.43 0.5 1 2 0 0 0 0 0 7 1 0 1 1 1 0 0 0 1 0 2 1 0 0 1 2 0 0
2019-12-02 vs. GSW $3.1K $3.5K 15 15.9 11.88 0.4 2 5 0 0 0 0 2 17.95 5 0.4 0 0 0 2 0 1 0 1 5 1 0 0 0 6 0 0
2019-11-30 @ HOU $3.1K $3.5K 9.5 8.4 18.57 0.2 1 5 1 0 2 0 1 16.24 5 0.2 0 0 2 2 0 2 2 0 7 0 0.5 1 0 4 0 0
2019-11-29 @ IND $3.1K $3.5K 3.5 4.5 10.75 0 0 5 0 0 0 0 0 19.83 2 0 0 3 2 0 0 1 2 1 5 0 0 0 0 0 0 0
2019-11-27 @ MIL $3.4K $3.5K 9.25 8 16.85 0.25 1 4 0 0 0 0 1 11.87 3 0.33 0 1 3 5 0 0 3 0 5 0 0 1 0 3 0 0
2019-11-25 vs. MIN $3.7K $3.6K 6.25 5.7 15.92 0.25 1 4 0 0 0 0 1 10.88 3 0.33 0 1 2 1 0 1 2 0 4 0 0 0 0 3 0 0
2019-11-23 vs. TOR $3.7K $3.6K 19.5 20.3 19.28 0.43 3 7 0 0 0 0 2 15.21 4 0.5 1 3 3 4 0 1 3 0 6 2 0 0 0.33 8 0 1
2019-11-22 @ DET $3.5K $3.6K 2.75 0.2 9.52 0.17 1 6 0 0 0 0 1 42.02 5 0.2 0 1 2 1 0 0 2 0 10 0 0 4 0 3 0 0
2019-11-20 vs. MIL $3K $3.6K 18.25 16.2 23.77 0.38 5 13 0 0 0 0 3 24.67 9 0.33 2 4 3 1 0 2 3 0 13 0 0 1 0.5 13 0 1
2019-11-17 @ LAL $3K $3.6K 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
2019-11-16 @ LAC $3.1K $3.6K 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
2019-11-14 @ PHX $3.2K $3.6K 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
2019-11-12 @ DEN $3.2K $3.7K 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
2019-11-10 @ POR $3.2K $3.7K 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
2019-11-08 vs. SAC $3.5K $3.7K 10.75 11.6 16.2 1 2 2 1 0 2 0 0 7.11 0 0 2 2 4 3 0 0 4 0 2 1 0.5 0 1 5 0 1
2019-11-06 vs. CHI $3.1K $3.5K 24.75 23.5 16.48 0.5 4 8 3 0 3 0 3 25.85 6 0.5 1 2 2 5 0 1 2 1 10.5 0 1 1 0.5 14 0 0
2019-11-05 vs. SAS $3K $3.5K 11.5 12.4 16.12 0.43 3 7 1 0 1 0 0 18.46 2 0 3 5 2 2 0 0 2 1 7.5 0 1 0 0.6 7 0 0
2019-10-31 vs. MIA $3.1K $3.5K 3.25 3.2 16.47 0.2 1 5 0 0 0 0 0 12.14 3 0 1 2 1 1 0 0 1 0 5 0 0 0 0.5 2 0 0
2019-10-29 @ MIA $3K $3.6K 8.25 7.2 18.22 0.38 3 8 0 0 0 0 1 19.76 6 0.17 2 2 1 1 0 0 1 0 9 0 0 1 1 7 0 0
2019-10-28 vs. PHI $3.1K $3.6K 11.25 12.1 10.72 0.4 2 5 0 0 0 0 0 19.89 3 0 2 2 0 3 0 1 0 1 5 0 0 0 1 4 0 0
2019-10-26 vs. ORL $3.1K $3.7K 8 8.9 11.92 0.33 1 3 0 0 0 0 0 11.17 2 0 1 1 0 2 0 1 0 1 3 0 0 0 1 2 0 0
2019-10-24 @ DET $3.1K $3.7K 1 0.5 10.23 0 0 2 0 0 0 0 0 13.02 2 0 0 0 1 0 0 1 1 0 3 0 0 1 0 0 0 0
2019-10-17 @ CHI -- -- 7.75 8.2 12.22 0.33 1 3 1 0 1 0 1 11.26 2 0.5 0 1 1 1 0 0 1 1 3.5 0 1 0 0 4 0 0
2019-10-16 @ NYK -- -- 22.5 17.8 22.92 0.55 6 11 0 0 0 0 5 26.18 10 0.5 1 1 4 4 0 0 4 0 15 0 0 4 1 17 0 0
2019-10-14 @ MIA -- -- 15 14.4 18.37 0.5 3 6 2 0 2 0 2 17.16 5 0.4 1 1 1 2 0 0 1 1 8 0 1 1 1 10 0 0
2019-10-09 vs. ORL -- -- 7 6 13.05 0.5 2 4 0 0 0 0 2 12.26 4 0.5 0 0 3 0 0 0 3 0 4 0 0 0 0 6 0 0
2019-10-07 vs. NOP -- -- 11.75 10.6 15.57 0.4 2 5 0 0 0 0 1 17.11 4 0.25 1 1 2 3 0 2 2 0 6 0 0 1 1 5 0 0
2019-04-10 vs. IND -- -- 3 4 12.07 0 0 4 1 0 2 0 0 16.17 3 0 0 1 2 0 0 0 2 0 5 1 0.5 0 0 1 0 0
2019-04-07 @ MIL -- -- 20.75 20.8 30.83 0.1 1 10 3 0 3 0 0 16.84 7 0 1 3 4 9 0 2 4 0 11.5 1 1 1 0.33 5 0 1
2019-04-05 @ ORL -- -- 19 19.5 21.65 0.5 3 6 2 0 2 0 3 17.02 5 0.6 0 1 1 0 0 1 1 1 9 2 1 2 0 11 0 0
2019-04-03 vs. PHI -- -- 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
2019-04-02 @ SAS -- -- 17.5 16.9 27.78 0.6 3 5 2 0 2 0 0 12.28 2 0 3 3 0 2 0 5 0 0 6 0 1 1 1 8 0 1
2019-03-31 vs. MIL -- -- 16 17.4 19.2 0.27 3 11 2 0 2 0 1 24.75 8 0.13 2 3 1 2 0 0 1 1 12 1 1 0 0.67 9 0 0
2019-03-29 vs. POR -- -- 16.25 15.6 15.92 0.38 3 8 0 0 0 0 3 20.1 7 0.43 0 1 3 3 0 0 3 1 7 0 0 0 0 9 0 1
2019-03-26 @ NOP -- -- 22.25 20.6 19.28 0.4 4 10 0 0 0 0 4 24.19 8 0.5 0 2 2 3 0 2 2 0 11 1 0 1 0 12 0 0
2019-03-23 vs. PHI -- -- 9.75 9.1 17.35 0.13 1 8 0 0 0 0 1 23.82 6 0.17 0 2 1 3 0 1 1 0 10 1 0 2 0 3 0 0
2019-03-21 vs. UTA -- -- 25.5 26.2 22.37 0.5 2 4 4 0 6 0 2 13.05 4 0.5 0 0 2 6 0 2 2 1 7 1 0.67 0 0 10 0 0
2019-03-19 vs. HOU -- -- 26.25 24.6 26.98 0.63 5 8 0 0 0 0 5 12.84 8 0.63 0 0 2 3 0 2 2 1 8 0 0 0 0 15 0 0
2019-03-17 @ ORL -- -- 17.5 18.5 26.93 0.38 3 8 0 0 0 0 2 13.35 6 0.33 1 2 1 0 0 3 1 2 8 0 0 0 0.5 8 0 0
2019-03-16 @ BOS -- -- 23.25 21.6 21.1 0.55 6 11 0 0 0 0 4 22.75 6 0.67 2 5 2 3 0 0 2 1 10 0 0 1 0.4 16 0 2
2019-03-13 vs. MEM -- -- 13.75 12.7 16.37 0.5 4 8 0 0 0 0 2 20.35 4 0.5 2 4 1 1 0 1 1 0 8 0 0 0 0.5 10 0 0
2019-03-10 vs. NOP -- -- 8 7.9 16.17 0 0 1 1 0 1 0 0 6.01 1 0 0 0 2 2 0 3 2 0 0.5 0 1 0 0 1 0 1
2019-03-09 vs. BKN -- -- 20 22.9 25.55 0.31 4 13 2 0 3 0 0 22.94 6 0 4 7 3 2 0 1 3 3 13.5 0 0.67 0 0.57 10 0 1
2019-03-06 vs. SAS -- -- 16.75 14.7 28.35 0.5 3 6 1 0 2 1 3 12.51 4 0.75 0 2 5 1 0 3 6 0 8 0 0.5 1 0 10 0 0
2019-03-04 @ MIA -- -- 33 30.3 25.93 0.5 7 14 0 0 0 0 7 22.11 11 0.64 0 3 1 4 0 1 1 1 14 0 0 0 0 21 0 0
2019-03-03 @ CHI -- -- 10 10.5 12.25 0.2 1 5 0 0 0 0 1 19.56 3 0.33 0 2 1 0 0 3 1 1 5 0 0 0 0 3 0 0
2019-03-01 vs. CHI -- -- 28.25 27.9 44.88 0.36 5 14 0 0 0 0 3 13.66 10 0.3 2 4 5 7 0 1 5 1 14 1 0 1 0.5 13 0 1
2019-02-27 vs. MIN -- -- 28.5 27.4 26.62 0.75 6 8 2 0 3 0 3 17.49 5 0.6 3 3 3 2 0 4 3 0 10.5 1 0.67 1 1 17 0 0
2019-02-25 @ HOU -- -- 10.5 8.4 13.15 0.43 3 7 0 0 0 0 2 27.38 4 0.5 1 3 4 2 1 0 5 0 9 0 0 2 0.33 8 0 0
2019-02-23 vs. PHX -- -- 0 0 5.58 0 0 2 0 0 0 0 0 14.34 1 0 0 1 0 0 0 0 0 0 2 0 0 0 0 0 0 0
2019-02-22 vs. DET -- -- 22.25 20.1 15.98 0.63 5 8 3 0 4 0 3 27.76 6 0.5 2 2 3 3 0 1 3 0 10 0 0.75 1 1 16 0 1
2019-02-14 vs. NYK -- -- 5.25 5.2 12.13 1 2 2 0 0 1 0 0 8.05 0 0 2 2 0 1 0 0 0 0 2.5 0 0 0 1 4 0 0
2019-02-12 vs. LAL -- -- 24.25 23.5 24.42 0.75 3 4 3 0 3 0 2 11.97 3 0.67 1 1 2 5 0 3 2 0 6.5 1 1 1 1 11 0 0
2019-02-10 vs. ORL -- -- 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
2019-02-09 vs. CHA -- -- 7.25 8.2 10.45 0.67 2 3 0 0 0 0 0 11.48 0 0 2 3 2 1 0 0 2 1 3 0 0 0 0.67 4 0 0
2019-02-07 vs. TOR -- -- 14.5 14.4 16.57 0.5 3 6 1 0 4 0 2 18.73 4 0.5 1 2 3 2 0 0 3 0 8 1 0.25 0 0.5 9 0 0
2019-02-04 @ WAS -- -- 24.5 24 15.53 0.75 6 8 0 0 0 0 4 24.88 6 0.67 2 2 3 0 0 2 3 2 9 0 0 1 1 16 0 0
2019-02-02 @ PHX -- -- 2.5 2.4 3.58 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 0 0 1 0 0 0 0 0 0 0 0 0
2019-02-01 @ UTA -- -- 2 3 13.33 0 0 1 0 0 0 0 0 3 1 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0
2019-01-30 @ SAC -- -- 0 0 3.9 0 0 1 0 0 0 0 0 10.26 1 0 0 0 1 0 0 0 1 0 1 0 0 0 0 0 0 0
2019-01-28 @ LAC -- -- 13 11.8 7.47 0.67 2 3 0 0 0 0 1 24.95 2 0.5 1 1 0 4 0 2 0 0 4 0 0 1 1 5 0 0
2019-01-26 @ POR -- -- 15.5 15.3 14.58 0.4 2 5 0 0 2 0 2 17.04 4 0.5 0 1 1 4 0 1 1 0 5 1 0 0 0 6 0 1
2019-01-23 @ CHI -- -- 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
2019-01-21 vs. ORL -- -- 4 3.9 6.87 0 0 2 0 0 0 0 0 13.57 1 0 0 1 1 2 0 1 1 0 1 0 0 0 0 0 0 1
2019-01-19 vs. BOS -- -- 10 10.9 8.42 1 2 2 0 0 0 0 0 11.07 0 0 2 2 1 2 0 1 1 0 1 1 0 0 1 4 0 1
2019-01-15 vs. OKC -- -- 15 13.5 15.17 0.57 4 7 0 0 0 0 3 24.6 6 0.5 1 1 2 0 0 1 2 1 9 0 0 2 1 11 0 0
2019-01-13 vs. MIL -- -- 9.25 7.6 12.4 0.25 1 4 0 0 0 0 1 21.48 4 0.25 0 0 4 3 0 2 4 0 4 0 0 2 0 3 0 2
2019-01-11 @ PHI -- -- 6 5.3 13.4 0 0 2 0 0 0 0 0 9.94 1 0 0 1 3 4 0 1 3 0 2 0 0 1 0 0 0 1
2019-01-09 @ BKN -- -- 10 11.4 14.77 0.25 1 4 0 0 0 0 1 10.83 3 0.33 0 1 2 2 0 0 2 1 3 1 0 0 0 3 0 1
2019-01-08 @ TOR -- -- 8.75 7.2 13.42 0.33 2 6 0 0 0 0 2 26.83 5 0.4 0 1 4 1 0 0 4 1 9 0 0 3 0 6 0 0
2019-01-06 vs. MIA -- -- 19.75 19.4 19.78 0.5 3 6 0 0 0 0 2 12.13 5 0.4 1 1 3 7 0 0 3 1 5 0 0 0 1 8 0 1
2019-01-04 @ MIL -- -- 10 9.5 8.87 0.67 2 3 0 0 0 0 2 19.53 3 0.67 0 0 0 0 0 1 0 0 4 1 0 1 0 6 0 0
2019-01-02 @ WAS -- -- 9 8.4 13.87 0.17 1 6 0 0 0 0 1 19.21 4 0.25 0 2 0 2 0 2 0 0 6 0 0 0 0 3 0 0
2018-12-31 @ IND -- -- 9.25 9.5 17.27 0 0 7 0 0 0 0 0 19.29 4 0 0 3 2 5 0 1 2 1 6 0 0 1 0 0 0 2
2018-12-29 vs. CLE -- -- 29.5 27.8 23.1 0.64 7 11 3 0 4 0 4 23.83 7 0.57 3 4 4 4 0 0 4 1 14 0 0.75 1 0.75 21 0 0
2018-12-28 @ MIN -- -- 18.75 18.1 13.62 0.5 3 6 0 0 0 0 3 24.46 6 0.5 0 0 1 3 0 1 1 2 8 0 0 2 0 9 0 0
2018-12-26 vs. IND -- -- 20.5 21.8 18 0.4 2 5 0 0 0 0 2 14.8 4 0.5 0 1 3 4 0 2 3 2 5 1 0 1 0 6 0 1
2018-12-23 @ DET -- -- 30.75 28.4 27.9 0.5 7 14 1 0 1 0 3 23.08 9 0.33 4 5 3 7 0 2 3 0 14.5 0 1 1 0.8 18 0 1
2018-12-21 @ NYK -- -- 8.5 7.7 13.52 0 0 3 0 0 0 0 0 12.81 3 0 0 0 1 6 0 1 1 0 4 0 0 1 0 0 0 0
2018-12-18 vs. WAS -- -- 17 16.2 20.97 0.4 2 5 0 0 0 0 2 15.26 4 0.5 0 1 4 6 0 0 4 2 6 0 0 3 0 6 0 2
2018-12-16 @ BKN -- -- 14 14.5 19.25 0.6 3 5 0 0 0 0 1 12.45 3 0.33 2 2 3 0 0 3 3 0 5 1 0 0 1 7 0 0
2018-12-14 @ BOS -- -- 15 15 16.17 0.63 5 8 0 0 2 0 2 21.97 3 0.67 3 5 0 0 0 0 0 0 9 1 0 0 0.6 12 0 0
2018-12-12 @ DAL -- -- 12.25 12.6 14.4 0.2 1 5 0 0 0 0 1 15.72 4 0.25 0 1 1 3 0 2 1 1 5 0 0 0 0 3 0 0
2018-12-08 vs. DEN -- -- 19.25 17.1 16.42 0.5 5 10 0 0 0 0 3 27.6 7 0.43 2 3 2 3 0 1 2 0 10 0 0 1 0.67 13 0 1
2018-12-05 vs. WAS -- -- 26.5 26.8 21.5 0.57 4 7 2 0 2 0 3 15.89 6 0.5 1 1 1 4 0 2 1 1 7 1 1 0 1 13 0 1
2018-12-03 vs. GSW -- -- 8.25 8.2 17.37 0.25 2 8 0 0 0 0 0 19.94 3 0 2 5 0 1 0 2 0 0 8 0 0 0 0.4 4 0 0
2018-11-30 @ OKC -- -- 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0
2018-11-28 @ CHA -- -- 5.25 6.2 9.33 0 0 3 2 0 2 0 0 16.63 2 0 0 1 0 1 0 0 0 0 4 1 1 0 0 2 0 0
2018-11-27 @ MIA -- -- 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
2018-11-25 vs. CHA -- -- 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
2018-11-23 vs. BOS -- -- 4 4.4 10.18 0 0 3 0 0 0 0 0 15.72 1 0 0 2 3 2 0 0 3 1 4 0 0 1 0 0 0 0
2018-11-21 vs. TOR -- -- 22.75 21.5 21.42 0.33 5 15 2 0 2 0 2 30.27 7 0.29 3 8 3 5 0 1 3 0 15 0 1 0 0.38 14 0 1
2018-11-19 vs. LAC -- -- 9.25 10.1 13.77 0.2 1 5 0 0 0 0 0 15.48 4 0 1 1 5 3 0 1 5 1 5 0 0 0 1 2 0 0
2018-11-17 @ IND -- -- 15 14.8 16.17 0.25 2 8 1 0 2 0 2 21.97 5 0.4 0 3 2 4 0 0 2 1 9 0 0.5 0 0 7 0 0
2018-11-15 @ DEN -- -- 13.75 12.2 16.48 0.67 4 6 0 0 0 0 3 14.56 5 0.6 1 1 2 1 0 0 2 0 5 0 0 0 1 11 0 1
2018-11-13 @ GSW -- -- 24 21.7 17.38 0.57 4 7 0 0 0 0 3 20.69 5 0.6 1 2 0 6 0 3 0 0 7 0 0 1 0.5 11 0 1
2018-11-11 @ LAL -- -- 7.25 8.2 21.13 0.33 2 6 0 0 0 0 0 11.36 3 0 2 3 0 1 0 0 0 0 6 1 0 0 0.67 4 0 0
2018-11-09 vs. DET -- -- 4.75 4.7 6.1 0.5 1 2 0 0 0 0 0 15.28 1 0 1 1 0 1 0 1 0 0 2 0 0 0 1 2 0 0
2018-11-07 vs. NYK -- -- 6.25 6.2 10.52 0.33 1 3 0 0 0 0 1 15.21 3 0.33 0 0 2 1 0 0 2 1 4 0 0 1 0 3 0 0
2018-11-06 @ CHA -- -- 17.75 20.7 22.77 0.5 2 4 2 0 2 0 1 10.91 2 0.5 1 2 1 1 0 1 1 2 6 2 1 1 0.5 7 0 0
2018-11-03 vs. MIA -- -- 20 20.4 18.68 0.71 5 7 1 0 2 1 1 18.29 2 0.5 4 5 1 2 0 2 2 1 7 0 0.5 0 0.8 12 0 1
2018-11-01 vs. SAC -- -- 7.5 7.4 16.3 0.33 1 3 0 0 0 0 1 9.82 3 0.33 0 0 1 2 0 0 1 0 4 1 0 1 0 3 0 0
2018-10-30 @ CLE -- -- 17.25 15.6 23.72 0.5 4 8 0 0 1 0 2 17.03 5 0.4 2 3 1 3 0 2 1 0 8.5 0 0 1 0.67 10 0 1
2018-10-29 @ PHI -- -- 15.5 16.8 20.28 0.29 2 7 0 0 0 0 0 17.08 3 0 2 4 1 4 0 2 1 2 7 0 0 1 0.5 4 0 1
2018-10-27 vs. CHI -- -- 21.5 20.9 23.17 0.44 4 9 0 0 0 0 4 17.83 7 0.57 0 2 5 2 0 1 5 1 10 1 0 1 0 12 0 0
2018-10-24 vs. DAL -- -- 15.25 15 25.7 0.4 2 5 0 0 0 0 2 7.78 4 0.5 0 1 0 5 0 0 0 1 5 0 0 0 0 6 0 0
2018-10-21 @ CLE -- -- 8 8 12.3 0.33 1 3 0 0 0 0 1 15.15 2 0.5 0 1 0 0 0 2 0 1 4 0 0 1 0 3 0 0
2018-10-19 @ MEM -- -- 17 16.9 20.25 0.29 2 7 4 0 4 0 2 17.96 5 0.4 0 2 2 2 0 1 2 0 9 1 1 0 0 10 0 0
2018-10-17 @ NYK -- -- 23.97 0.44 4 9 2 0 2 0 2 19.82 6 0.33 2 3 5 2 0 0 5 0 12 0 1 2 0.67 12 0 0

Vince Carter Daily Fantasy News, Rankings, Projections

Vince Carter has been ruled out

Vince Carter is out, and with John Collins back, there is plenty of reason to take a look at John Collins on this slate. If Taurean Prince and Alex Len eventually get ruled out, this situation becomes even more attractive.

4/03/19, 10:47 AM ET

John Collins (illness) out Sunday; Kevin Huerter (back), Alex Len (knee), and Vince Carter (knee) available to play

Collins has officially been downgraded from doubtful and won't play in Sunday's matchup against the Chicago Bulls due to flu-like symptoms that have now forced him to miss two consecutive games, while Huerter, Len, and Carter have all been cleared and will be available to play despite dealing with their respective ailments. With Omari Spellman already ruled out, head coach Lloyd Pierce already confirmed that Alex Len will start alongside Dewayne Dedmon in the frontcourt, and he is coming off of a phenomenal fantasy performance relative to his price tag in 36 minutes of action in Friday's four-overtime thriller.

3/03/19, 2:05 PM ET

Omari Spellman will start ahead of Vince Carter on Saturday

Head coach Llyod Pierce has officially announced that Spellman will start at power forward in Saturday's matchup against the Miami Heat, which will send Vince Carter to the bench to assume a reserve role for at least one game. Pierce didn't specify if that was a matchup-based lineup change, so it'll be interesting to see if Spellman can lock down the starting power forward role while John Collins is still sidelined. Spellman has logged at least 20 minutes in each of the Hawks last three games, and he'll be an intriguing tournament target for near minimum salary if he's able to see his playing time rise into the upper-20s this evening. He hasn't been a high usage player in the second unit but has still averaged 0.83 DraftKings and 0.81 FanDuel points per minute through seven games this season.

11/03/18, 5:52 PM ET

Vince Carter (personal) available to play Monday

Carter is back with the Sacramento Kings and will be available to play in Monday's game against the Detroit Pistons after missing two consecutive games dealing with a personal matter. While Carter will likely be active, it doesn't necessarily mean he's guaranteed to see the floor in head coach Dave Joerger's inconsistent rotations. Zach Randolph was on the receiving of a DNP-CD in Saturday's loss, so his chances of playing tonight seem pretty good, though it remains unclear at this time whether he'd displace Skal Labissiere from the starting power forward spot or come off the bench. Labissiere only logged 21 minutes in three-quarters of action because of the blowout loss, so it'd be safe to project that he would be allocated more playing time in the frontcourt rotation than Randolph regardless of starting lineup.

3/19/18, 12:46 PM ET

Vince Carter (personal) remains out Saturday

Carter has been officially ruled out and won't play in Saturday's game against the Utah Jazz as he tends to a personal matter that has now forced him to miss two consecutive games. The Sacramento Kings are currently in the midst of a brutal stretch of five games in seven nights, so it'd be far from surprising to see one or two of their veteran players rested on the second leg of a back-to-back set, but in all likelihood, the status of players like Zach Randolph, Garrett Temple, and Kosta Koufos won't be known prior to game time per usual. That said, if the Kings starting lineup is confirmed before tip-off without Randolph included, it'll be a fair assumption that he's unlikely to play.

3/17/18, 6:30 PM ET

Vince Carter (intercostal strain) questionable Tuesday

Carter has officially been listed as questionable on the Sacramento Kings' injury report for tonight's game against the Los Angeles Clippers due to a strained intercostal and ribs injury that had forced him to be a late scratch prior to Saturday's loss. Meanwhile, De'Aaron Fox is slated to miss the next two weeks, so Buddy Hield could possibly draw the start at shooting guard for the second time in as many games after easily exceeding salary-based expectations in 31 minutes on Saturday night. If he doesn't it, it would be Bogdan Bogdanovic that would reenter the starting lineup, though both wing players should be in line for increased minutes if Carter is unavailable, as head coach Dave Joerger essentially opted to utilize an eight-man rotation in the previous game with Malachi Richardson and Justin Jackson each seeing less than 10 minutes a piece.

12/26/17, 11:39 AM ET

Buddy Hield (ankle) ruled out Monday; Vince Carter (illness) remains out

Hield has been ruled out and won’t suit up for tonight’s game against the Denver Nuggets with a sprained right ankle that has now forced him to miss two consecutive games, while Vince Carter remains out for the seventh consecutive game as he continues to deal with a bout of kidney stones. The Kings should continue to roll with a new-look starting lineup for Monday's contest with De'Aaron Fox and Skal Labissiere starting ahead of Bogdan Bogdanovic and Willie Cauley-Stein, respectively. Though, since his "demotion" Cauley-Stein averaged nearly 32 minutes of action per game. With Hield unavailable, Bogdanovic is virtually guaranteed to re-enter the starting lineup for the second time in as many games. There hasn't really been one direct beneficiary with Hield and Carter off the court this season, but Cauley-Stein and Frank Mason have each seen at least a +2.4% usage rate differential in the aforementioned scenario, putting them all in play for Monday's slate, though Mason will likely only see around 20 minutes of playing time, reserving him to tournament punt status only.

11/20/17, 2:20 PM ET

Buddy Hield (ankle) and Vince Carter (illness) ruled out Saturday

Hield has been ruled out and won't suit up for tonight's game against the Portland Trail Blazers after he was previously considered unlikely to play due to a sprained left ankle, while Vince Carter continues to deal with kidney stones and will miss his sixth consecutive game. The Kings rolled with a new-look starting lineup for Friday's contest with De'Aaron Fox and Skal Labissiere starting ahead of Bogdan Bogdanovic and Willie Cauley-Stein, though it has yet to be confirmed whether that will be the new starting unit moving forward. With Hield unavailable, Bogdanovic is virtually guaranteed to re-enter the starting lineup for one-game at the very least. There hasn't really been one direct beneficiary with Hield and Carter off the court this season, but Cauley-Stein, Fox, and Zach Randolph have all seen at least a +2.0% usage rate differential in the aforementioned scenario, putting them all in play for Saturday's slate regardless of the Kings starting lineup.

11/18/17, 12:32 PM ET

Vince Carter (illness) remains out Wednesday

Carter has been ruled out and won’t play in tonight’s game against the Atlanta Hawks as he continues to deal with kidney stones that have now forced him to miss four consecutive games. It's tough to pinpoint exactly where Carter's playing time will be allocated given Sacramento Kings head coach Dave Joerger's inconsistent rotations, but Justin Jackson has seen at least 25 minutes or more in each of the last three games Carter has been sidelined. That said, Jackson is priced near minimum salary across the industry and collects enough peripheral stats on the defensive end to be viable as a deep flier in tournaments on Wednesday's slate, especially if he continues to average double-digit shot attempts per game like he has in three of the four Kings' previous matchups.

11/15/17, 4:43 PM ET

Vince Carter (illness) remains out Monday

Carter has been ruled out and won’t play in tonight’s game against the Washington Wizards as he continues to deal with kidney stones that have now forced him to miss three consecutive games. It's tough to pinpoint exactly where Carter's playing time will be allocated given Sacramento Kings head coach Dave Joerger's inconsistent rotations, but Justin Jackson has seen at least 25 minutes or more in each of the last two games Carter has been sidelined. That said, Jackson is priced near minimum salary across the industry and collects enough peripheral stats on the defensive end to be a viable punt option in tournaments on Monday's slate, especially if he continues to average 12 shot attempts per game like he has in the Kings' previous three matchups.

11/13/17, 11:27 AM ET